Evidence map›Paper›PMID 32829984›Full record

ArticleSchizophrenia research2020

Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.

William C Hochberger, Courtney L M Eskridge, Jeffrey R Bishop, James L Reilly, Leah H Rubin, Sarah Keedy, Elliot S Gershon, Carol A Tamminga, Godfrey D Pearlson, Michael Ragozzino and 3 more

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

William C HochbergerVISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, United States; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
Courtney L M EskridgeDepartment of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States.
Jeffrey R BishopDepartment of Experimental and Clinical Pharmacology & Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States.
James L ReillyDepartment of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL, United States.
Leah H RubinDepartment of Neurology, Johns Hopkins University, Baltimore, MD, United States.
Sarah KeedyDepartment of Psychiatry, University of Chicago Medicine, Chicago, IL, United States.
Elliot S GershonDepartment of Psychiatry, University of Chicago Medicine, Chicago, IL, United States.
Carol A TammingaDepartment of Psychiatry, University of Texas Southwestern, Dallas, TX, United States.
Godfrey D PearlsonDepartment of Psychiatry and Neurobiology, Yale University and Olin Neuropsychiatric Research Center, Hartford, CT, United States.
Michael RagozzinoDepartment of Psychology, University of Illinois, Chicago, IL, United States.
Matcheri S KeshavanBeth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
John A SweeneyDepartment of Psychiatry and Behavioral Neurosciences, University of Cincinnati, OH, United States.
S Kristian HillDepartment of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States. Electronic address: scot.hill@rosalindfranklin.edu.
Rosalind Franklin University of Medicine and Science · USUniversity of Chicago · USBeth Israel Deaconess Medical Center · USJohns Hopkins University · USNorthwestern University · USThe University of Texas Southwestern Medical Center · USUniversity of California San Diego · USUniversity of Cincinnati Medical Center · USUniversity of Illinois Chicago · USUniversity of Minnesota · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2007 to 2019
$7.8M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077945 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2007 to 2019
$7.6M
Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077852 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI THAKER, GUNVANT K · 2007 to 2010
$3.5M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077862 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SWEENEY, JOHN A · 2007 to 2010
$3.1M
Schizophrenia Pharmacogenetics: cognition and symptom response to antipsychoticsK08MH083888 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BISHOP, JEFFREY R · 2009 to 2013
$899k
Enhancing Cognition in SchizophreniaK23MH072767 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HILL, SCOT KRISTIAN · 2006 to 2010
$794k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS K08 MH083888NIMH NIH HHS K23 MH072767NIMH NIH HHS R01 MH077851NIMH NIH HHS R01 MH077852NIMH NIH HHS R01 MH077862NIMH NIH HHS R01 MH077945NIMH NIH HHS R01 MH078113
6 · The paper itself

Abstract

Dopaminergic activity in prefrontal cortex is modulated by the low (Met) and high (Val) activity of the rs4680 Val158Met single nucleotide polymorphism (SNP) in the Catechol-O-Methyltransferase (COMT) gene. While this has been related to working memory maintenance in patients with schizophrenia, the familial pattern, impact across the psychosis spectrum, and the role of this genotype on other aspects of behavior, such as cognitive flexibility, remains unclear. The relationship between COMT Val158Met genotype and both cognitive stability and flexibility were assessed using the Penn Conditional Exclusion Test (PCET) in healthy controls (n = 241), patients with psychotic disorders (n = 542), and their first-degree relatives (n = 613) from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. Higher rates of perseverative errors (poor flexibility) were associated with the low-activity COMT genotype (Met allele carriers) in probands compared to their first-degree relatives with the same genotype. Probands and first-degree relatives homozygous for the high-activity COMT enzyme (Val/Val) showed elevated rates of regressive errors (poor stability) compared to controls. Conversely, heterozygous relatives had comparable regressive error rates to controls, with probands showing elevated errors in comparison. These findings suggest that impaired suppression of learned response patterns and reduced stability of mental sets may be a familial intermediate cognitive phenotype related to Val COMT allele genotype.

Indexed as

Psychotic DisordersSchizophreniaCatechol O-MethyltransferaseCognitionGenotypeHumansPolymorphism, Single NucleotideCatechol O-MethyltransferaseB-SNIP 1Catechol-O-methyltransferase (COMT)Penn conditional exclusion task (PCET)PsychosisSet shifting

Identifiers

PMID32829984
PMCPMC7704884
OpenAlexW3080879719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.